2 results
Approved WMOWill not start
The purpose of this study is to evaluate the possible risks and efficacy (improvement of disease) with an experimental oral study drug named eliglustat in pediatric patients from 2 to 18 years with Gaucher disease.
Approved WMOPending
The primary objective is to determine the safety, tolerability and feasibility of pre-surgical lyso-thermosensitive liposomal doxorubicin (ThermoDox) + MR-HIFU induced local hyperthermia therapy in metastatic breast cancer. The secondary objectives…